title: Nanomedicine: Past, present and future - A global perspective.
abstract: Nanomedicine is an emerging and rapidly evolving field and includes the use of nanoparticles for diagnosis and therapy of a variety of diseases, as well as in regenerative medicine. In this mini-review, leaders in the field from around the globe provide a personal perspective on the development of nanomedicine. The focus lies on the translation from research to development and the innovation supply chain, as well as the current status of nanomedicine in industry. The role of academic professional societies and the importance of government funding are discussed. Nanomedicine to combat infectious diseases of poverty is highlighted along with other pertinent examples of recent breakthroughs in nanomedicine. Taken together, this review provides a unique and global perspective on the emerging field of nanomedicine.
authors.affiliation: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington D.C., USA. Electronic address: change@georgetown.edu.
authors.forename: Esther H
authors.initials: EH
authors.lastname: Chang
authors.affiliation: SynerGene Therapeutics, Inc., Potomac, MD, USA.
authors.forename: Joe B
authors.initials: JB
authors.lastname: Harford
authors.affiliation: European Technology Platform on Nanomedicine, c/o VDI/VDE Innovation + Technik GmbH, Berlin, Germany.
authors.forename: Michael A W
authors.initials: MA
authors.lastname: Eaton
authors.affiliation: European Technology Platform on Nanomedicine, c/o VDI/VDE Innovation + Technik GmbH, Berlin, Germany.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Boisseau
authors.affiliation: CSIR Materials Science and Manufacturing, Polymers & Composites, Pretoria, South Africa.
authors.forename: Admire
authors.initials: A
authors.lastname: Dube
authors.affiliation: CSIR Materials Science and Manufacturing, Polymers & Composites, Pretoria, South Africa.
authors.forename: Rose
authors.initials: R
authors.lastname: Hayeshi
authors.affiliation: CSIR Materials Science and Manufacturing, Polymers & Composites, Pretoria, South Africa.
authors.forename: Hulda
authors.initials: H
authors.lastname: Swai
authors.affiliation: Department of Nuclear Medicine, Department of Molecular Medicine and Pharmaceutical Sciences, Seoul National University, Seoul, South Korea.
authors.forename: Dong Soo
authors.initials: DS
authors.lastname: Lee
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D003952:Diagnostic Imaging / Q000639:trends*; D015195:Drug Design; D005544:Forecasting; D038622:Internationality; D050997:Nanomedicine / Q000639:trends*; D053758:Nanoparticles / Q000627:therapeutic use*
keywords: Diagnostics; Drug delivery; Funding; Imaging; Innovation; Nanomedicine